Percutaneous Treatment of Carpal Tunnel Syndrome With Scan (ECHOCARPE)
|ClinicalTrials.gov Identifier: NCT02514317|
Recruitment Status : Completed
First Posted : August 3, 2015
Last Update Posted : August 3, 2015
|Condition or disease||Intervention/treatment||Phase|
|Carpal Tunnel Syndrome||Procedure: percutaneous treatment Device: Ultrasound||Phase 2|
Ultrasound analysis of Carpal tunnel is used for many years, especially for diagnostic purposes. Investigators have shown, first by a study of 104 cadavers that it was possible to reduce the opening by making the gesture under ultrasound guidance and to perform the procedure under local anesthesia. Then investigators performed an open study of 25 patients confirming the absence of iatrogenic lesions with this new technique.
The percutaneous treatment of carpal tunnel syndrome under ultrasound guidance is a gesture of interventional radiology. One can envisage making this type of treatment in interventional radiology room which overcomes the operating room and thus reduce costs.
The objective of the study is to continue the study of percutaneous treatment of carpal tunnel syndrome under ultrasound guidance by an open study conducted in interventional radiology room.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Ultrasound-assisted Percutaneous Release of Carpal Tunnel Syndrome|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||March 2013|
|Actual Study Completion Date :||April 2013|
Experimental: percutaneous treatment
percutaneous treatment of carpal tunnel syndrome under ultrasound guidance in interventional radiology room.
Procedure: percutaneous treatment
- Pain (visual analogic scale) [ Time Frame: change between baseline and day 90 after surgery ]visual analogic scale
- paresthesia [ Time Frame: change between baseline and day 90 after surgery ]
- muscle strength (dynamometer JAMARD) [ Time Frame: change between baseline and day 90 after surgery ]dynamometer JAMARD
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02514317
|Caen, France, 14000|